In the present study, we first analysed the differential expression of nCD64 in patients with PTB, ePTB, long‐term anti‐TB treatment (anti‐TB) and healthy controls (HC); monocytes CD64 (mCD64) and lymphocytes CD64 (lymCD64) were used as the positive and negative controls, respectively. The gene discussed is FCGR1A; the disease is tuberculosis.